• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I B12 REAGENT KIT; RADIOASSAY, VITAMIN B12

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I B12 REAGENT KIT; RADIOASSAY, VITAMIN B12 Back to Search Results
Catalog Number 07P67-22
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/12/2023
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product, list number 7p67-22 / 32 / 74 / 77 and there is a similar product distributed in the us, list number 7p67-21 / 31.All available patient information was included.Additional patient details are not available.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported issues with controls being out of range and also reported inconsistent alinity i b12 results.The customer is not certain which results are the correct results.The customer provided the following data after the regent was recalibrated: customer normal range is > 200 pg/ml sample id (b)(6) result from 12 july was <148, result from 12 july in the afternoon was 183, and result from 13 july was 361 sample id (b)(6) result from 12 july was <148, result from 12 july in the afternoon was 155, and result from 13 july was 349 sample id (b)(6) result from 12 july was 152, result from 12 july in the afternoon was 181, and result from 13 july was 359 sample id (b)(6) result from 12 july was 171, result from 12 july in the afternoon was 164, and result from 13 july was 543 there was no reported impact to patient management.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and in-house testing.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.The ticket search by lot did not identify an increase complaint activity for the complaint lot.Ticket trending review did not identify any trends regarding commonalities for complaint issue and lot.Device history review did not identify any related non-conformances or deviations with the complaint lot and complaint issue.In-house testing was performed for 51430ud00, which met acceptance and validity criteria for abbott controls and suggests that the product is performing as expected.Labeling was reviewed and sufficiently addresses the customer¿s issue.Based on the investigation, no systemic issue or deficiency of the alinity i b12 reagent lot 51430ud00 was identified.
 
Event Description
The customer reported issues with controls being out of range and also reported inconsistent alinity i b12 results.The customer is not certain which results are the correct results.The customer provided the following data after the regent was recalibrated: customer normal range is > 200 pg/ml sample id (b)(6) result from 12 july was <148, result from 12 july in the afternoon was 183, and result from 13 july was 361.Sample id (b)(6) result from 12 july was <148, result from 12 july in the afternoon was 155, and result from 13 july was 349.Sample id (b)(6) result from 12 july was 152, result from 12 july in the afternoon was 181, and result from 13 july was 359.Sample id (b)(6) result from 12 july was 171, result from 12 july in the afternoon was 164, and result from 13 july was 543.There was no reported impact to patient management.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I B12 REAGENT KIT
Type of Device
RADIOASSAY, VITAMIN B12
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key17400486
MDR Text Key320252149
Report Number3005094123-2023-00195
Device Sequence Number1
Product Code CDD
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K121314
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/26/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/12/2024
Device Catalogue Number07P67-22
Device Lot Number51430UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/16/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, AI25087; ALNTY I PROCESSING MODU, 03R65-01, AI25087
-
-